Organisations working at the intersection of policy analysis and advocacy to advance evidence-based psychedelic reform.
Policy Advocacy
Compare organizations by country coverage, audience, and advocacy activity. Activity tags describe the organization overall unless the profile has country-specific project evidence.
28
organisations
14
countries
15
activities
Global or regional organizations without country-specific coverage set.
6 orgs
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Beckley Foundation Drug Policy Reform Organizations | Patients & familiesClinicians+4 | Policy Briefing and ConsultationCoalition Building+2 Controlled Substance / Scheduling ReformResearch and Evidence Policy Briefing+5 Org-level | Cross-country | Profile |
Chacruna Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+4 | Public Education CampaigningPolicy Briefing and Consultation+2 Public Education and AwarenessResearch and Evidence Policy Briefing+5 Org-level | Cross-country | Profile |
European Association for Palliative Care (EAPC) Drug Policy Reform Organizations | Patients & familiesClinicians+5 | Policy Briefing and ConsultationCoalition Building+2 Health System Implementation PolicyResearch and Evidence Policy Briefing+4 Org-level | Cross-country | Profile |
ICEERS Drug Policy Reform Organizations | Patients & familiesClinicians+5 | Policy Briefing and ConsultationCoalition Building+2 Controlled Substance / Scheduling ReformHarm Reduction Policy+5 Org-level | Cross-country | Profile |
Students for Sensible Drug Policy Drug Policy Reform Organizations | Patients & familiesClinicians+4 | Public Education CampaigningCoalition Building+2 DecriminalizationControlled Substance / Scheduling Reform+4 Org-level | Cross-country | Profile |
Transform Drug Policy Foundation Drug Policy Reform Organizations | Advocates & community organizationsResearchers+3 | Legislative AdvocacyPublic Education Campaigning+2 DecriminalizationControlled Substance / Scheduling Reform+4 Org-level | Cross-country | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
Cross-countryAudience
Activities
Countries
Cross-countryDrug Policy Reform Organizations
Audience
Activities
Countries
Cross-countryAudience
Activities
Countries
Cross-countryDrug Policy Reform Organizations
Audience
Activities
Countries
Cross-countryDrug Policy Reform Organizations
Audience
Activities
Countries
Cross-country2 orgs
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Mind Medicine Australia Drug Policy Reform Organizations | Patients & familiesClinicians+3 | Legislative AdvocacyPolicy Briefing and Consultation+3 Medical Access PathwaysHealth System Implementation Policy+2 Org-level | Australia | Profile |
Psychedelic Research in Science & Medicine (PRISM) Drug Policy Reform Organizations | Patients & familiesClinicians+4 | Policy Briefing and ConsultationCoalition Building+2 Medical Access PathwaysControlled Substance / Scheduling Reform+5 Org-level | Australia | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
Drug Policy Reform Organizations
Audience
Activities
Countries
1 org
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Psychedelic Society Belgium Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+2 | Public Education CampaigningCoalition Building+1 Medical Access PathwaysControlled Substance / Scheduling Reform+3 Org-level | Belgium | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
1 org
1 org
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Czech Psychedelic Society (CZEPS) Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+2 | Legislative AdvocacyPublic Education Campaigning+2 Controlled Substance / Scheduling ReformMedical Access Pathways+3 Org-level | Czechia | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
1 org
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
MAPS Europe B.V. Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+3 | Policy Briefing and ConsultationCoalition Building+2 Medical Access PathwaysHealth System Implementation Policy+5 Org-level | GermanyNetherlands+2 | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
1 org
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Kykeon/Greek Psychedelic Society Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+2 | Public Education CampaigningPolicy Briefing and Consultation+1 Controlled Substance / Scheduling ReformMedical Access Pathways+3 Org-level | Greece | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
1 org
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Icelandic Psychedelic Society - Hugvikkandi Drug Policy Reform Organizations | Patients & familiesClinicians+3 | Public Education CampaigningCoalition Building+1 Controlled Substance / Scheduling ReformResearch and Evidence Policy Briefing+2 Org-level | Iceland | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
2 orgs
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Italian Society for Psychedelic Medicine - SIMEPSI Drug Policy Reform Organizations | Patients & familiesClinicians+3 | Policy Briefing and ConsultationCoalition Building+1 Medical Access PathwaysControlled Substance / Scheduling Reform+3 Org-level | Italy | Profile |
Luca Coscioni Association Drug Policy Reform Organizations | Patients & familiesClinicians+3 | Legislative AdvocacyPolicy Briefing and Consultation+4 Controlled Substance / Scheduling ReformMedical Access Pathways+4 Org-level | Italy | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
Drug Policy Reform Organizations
Audience
Activities
Countries
1 org
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
MAPS Europe B.V. Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+3 | Policy Briefing and ConsultationCoalition Building+2 Medical Access PathwaysHealth System Implementation Policy+5 Org-level | GermanyNetherlands+2 | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
1 org
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
MAPS Europe B.V. Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+3 | Policy Briefing and ConsultationCoalition Building+2 Medical Access PathwaysHealth System Implementation Policy+5 Org-level | GermanyNetherlands+2 | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
2 orgs
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Swiss Medical Association for Psychedelic Therapy (SÄPT) Drug Policy Reform Organizations | Patients & familiesClinicians+5 | Policy Briefing and ConsultationCoalition Building+2 Medical Access PathwaysHealth System Implementation Policy+5 Org-level | Switzerland | Profile |
Swiss Medical Society for Psycholytic Therapy Drug Policy Reform Organizations | Patients & familiesClinicians+4 | Policy Briefing and ConsultationCoalition Building+2 Medical Access PathwaysHealth System Implementation Policy+5 Org-level | Switzerland | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
Drug Policy Reform Organizations
Audience
Activities
Countries
1 org
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Ukrainian Psychedelic Research Association Patient Advocacy Organizations | Patients & familiesVeterans & first responders+4 | Policy Briefing and ConsultationCoalition Building+1 Medical Access PathwaysHealth System Implementation Policy+2 Org-level | Ukraine | Profile |
Patient Advocacy Organizations
Audience
Activities
Countries
5 orgs
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
Centre for Evidence Based Drug Policy Think Tanks | Patients & familiesClinicians+3 | Policy Briefing and ConsultationCoalition Building+3 Controlled Substance / Scheduling ReformHealth System Implementation Policy+4 Org-level | United Kingdom | Profile |
Drug Science Drug Policy Reform Organizations | Patients & familiesClinicians+4 | Policy Briefing and ConsultationCoalition Building+2 Controlled Substance / Scheduling ReformMedical Access Pathways+5 Org-level | United Kingdom | Profile |
MAPS Europe B.V. Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+3 | Policy Briefing and ConsultationCoalition Building+2 Medical Access PathwaysHealth System Implementation Policy+5 Org-level | GermanyNetherlands+2 | Profile |
Psilocybin Access Rights Patient Advocacy Organizations | Patients & familiesClinicians+4 | Legislative AdvocacyPublic Education Campaigning+2 Medical Access PathwaysControlled Substance / Scheduling Reform+2 Org-level | United Kingdom | Profile |
Release Drug Policy Reform Organizations | Patients & familiesClinicians+5 | Legislative AdvocacyPublic Education Campaigning+3 DecriminalizationControlled Substance / Scheduling Reform+5 Org-level | United Kingdom | Profile |
Think Tanks
Audience
Activities
Countries
Drug Policy Reform Organizations
Audience
Activities
Countries
Drug Policy Reform Organizations
Audience
Activities
Countries
Patient Advocacy Organizations
Audience
Activities
Countries
Audience
Activities
Countries
5 orgs
| Organisation | Audience | Activities | Countries | Profile |
|---|---|---|---|---|
American Academy of Child Adolescent Psychiatry. Drug Policy Reform Organizations | Patients & familiesClinicians+4 | Policy Briefing and ConsultationPublic Education Campaigning+2 Research and Evidence Policy BriefingPublic Education and Awareness+4 Org-level | United States | Profile |
Drug Policy Alliance Drug Policy Reform Organizations | Patients & familiesClinicians+4 | Legislative AdvocacyPublic Education Campaigning+2 DecriminalizationControlled Substance / Scheduling Reform+5 Org-level | United States | Profile |
IHPI Drug Policy Reform Organizations | Patients & familiesVeterans & first responders+4 | Policy Briefing and ConsultationCoalition Building+1 Medical Access PathwaysControlled Substance / Scheduling Reform+3 Org-level | United States | Profile |
National Network of Depression Centers Drug Policy Reform Organizations | CliniciansResearchers+1 | Coalition BuildingPolicy Briefing and Consultation+2 Medical Access PathwaysHealth System Implementation Policy+4 Org-level | United States | Profile |
SCPTR Drug Policy Reform Organizations | CliniciansAdvocates & community organizations+3 | Public Education CampaigningPolicy Briefing and Consultation+2 Medical Access PathwaysControlled Substance / Scheduling Reform+5 Org-level | United States | Profile |
Drug Policy Reform Organizations
Audience
Activities
Countries
Drug Policy Reform Organizations
Audience
Activities
Countries
Audience
Activities
Countries
Drug Policy Reform Organizations
Audience
Activities
Countries
Audience
Activities
Countries